Radiopharm Theranostics RADX
NASDAQ RADX
$1.43 -0.05 (-3.39%)
As of: Oct 2, 2026 · 3:21 PM EDT

Radiopharm Theranostics (RADX) Short-term Investments (2024)

Updated

Radiopharm Theranostics (RADX) recorded Short-term Investments of $40,000 in fiscal Q2 2025 (quarter ended Dec 31, 2024).

Analysis

Radiopharm Theranostics (RADX) Short-term Investments (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Radiopharm Theranostics 5.74 Bn 5.70 Bn 186,835.86
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 40,000.00
Jun 30, 2024 263.61
API Access

Radiopharm Theranostics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=RADX&period=max&api_key=YOUR_API_KEY